Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis

NCT07760831 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.

NCT NCT07760831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07760831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
September 30, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe ulcerative colitis